Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cryoport Inc (NQ: CYRX )

16.62 -0.19 (-1.13%)
Streaming Delayed Price Updated: 10:04 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cryoport Inc

The Law Offices of Frank R. Cruz Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Cryoport, Inc. (NASDAQ:CYRX) Investor Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 08/09/2023 -- Cryoport, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.